AI assistant
Sending…
LABCORP HOLDINGS INC. — Director's Dealing 2016
Jan 8, 2016
30237_dirs_2016-01-08_bd038dce-1d22-4842-9518-ad7c754cb183.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2016-01-01
Reporting Person: Keller Deborah L (CEO, Covance Drug Development)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 11412 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Unit | $0 | Common Stock (3660) | Direct | ||
| Restricted Stock Unit | $0 | Common Stock (23420) | Direct |
Footnotes
F1: The Restricted Stock Units vest in three equal annual installments beginning on 3/11/16.
F2: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F3: The Restricted Stock Units vest in two equal annual installments beginning on 3/11/16.
More from LABCORP HOLDINGS INC.
Regulatory Filings
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 26
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 4
Earnings Release
2026
Apr 30
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Notice of Dividend Amount
2026
Apr 9
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Mar 30